Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. - Wikidata - wikimedia - TriplyDB

Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.

Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.

http://www.wikidata.org/entity/Q42504104

about

Glucagon secretion and signaling in the development of diabetes Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly Diabetes in Patients With Acromegaly.Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.Glucose decouples intracellular Ca2+ activity from glucagon secretion in mouse pancreatic islet alpha-cells Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumors SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells.Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.The somatostatin receptor subtype 5 in neuroendocrine tumours.Adverse events associated with somatostatin analogs in acromegaly.Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice.Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma.Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues.Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC)International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

P2860

Q21129250-281BBFC0-F110-4068-A147-C2C15D5E6005 Q28069603-53E7EB98-7A39-4F3F-8A65-0D2AC508D469 Q30238646-04C045AC-5D78-4CB5-BC55-3013A66A891F Q34234967-F9C43CA3-B629-42FE-B739-DFB90F49483C Q34329427-BCF7640C-3F60-4DB6-BF37-2BAB8429ACE1 Q34450543-20440DD6-3861-4B28-8D44-C877DB3666BD Q35268662-02193117-97D2-42E7-92C2-35A4D7B5848D Q35747137-2F23776D-0E9E-473B-8312-2DF3A753D270 Q36382533-99CFE503-1006-444A-B11A-944D36AB472E Q36911589-C03FF083-6F89-4AFA-91EE-15D26A2110D4 Q36990184-954F951F-DAC4-4A26-ACC0-8BFD3E952B9F Q37691450-E0C91399-EFBD-4CD3-A7AB-59108EEBB997 Q38548973-D67669C7-1038-484E-8D26-0DA5F8FA3DA7 Q38912799-FDE3C314-5A81-4B44-B040-4197EC85A4F1 Q39146196-41BE714F-4E7A-414C-A918-4EFE16269D46 Q39164157-9ED08E5B-C575-44CB-96A7-DF78398B4A8D Q41354110-179F3532-735D-487F-BF61-EF422BFC9B80 Q42138516-005A9AEF-24CC-45AD-A317-956C60126664 Q43083184-8F0B6595-1587-4BB0-AEFB-2054558BBA7D Q48152509-B97B5A97-D527-4C35-8219-4A32AC2F2BC4 Q51374462-E9AB3D7B-89C0-4E01-A232-62494DEE0E18 Q57142659-8B8E60C1-8BD1-4F17-86BD-C4FB2003F94A Q57144951-3EF63C3A-0E3C-4D71-9ABC-C3AC0246A3BF

P2860

Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.

http://www.wikidata.org/entity/Q42504104

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Characterization of somatostat ...... lated human pancreatic islets.

@en

Characterization of somatostat ...... lated human pancreatic islets.

@nl

type

label

Characterization of somatostat ...... lated human pancreatic islets.

@en

Characterization of somatostat ...... lated human pancreatic islets.

@nl

prefLabel

Characterization of somatostat ...... lated human pancreatic islets.

@en

Characterization of somatostat ...... lated human pancreatic islets.

@nl

P1433

Q42504104-F5065506-E1C1-4349-9528-FF40D40CD8B6

P1476

Q42504104-90120298-E694-4EF1-BCAA-6FD06FADA083

P2093

Q42504104-17D29D0B-1F31-4AEF-B940-8BB3227571B1

Q42504104-1A6AE859-2C53-416E-A8AB-AC572653220F

Q42504104-1ED3164B-35B8-4D3C-9C05-636F9B390B13

Q42504104-75249767-2AD5-48F0-93A6-DFD39DE680D7

Q42504104-7873111F-CA07-47EB-9D12-B2AB7060C135

Q42504104-824E7D33-8F6A-4011-B641-ADD72F794593

Q42504104-E22DD566-A5C7-4951-810B-697A3F42D505

Q42504104-E3014908-B4A3-4C19-875B-7751E4BBF6A0

Q42504104-FCC14AE6-AACF-4024-908A-4CBD2748BFE3

P304

Q42504104-1C593556-D973-4DC2-B6A3-7660B34A703D

P31

Q42504104-4F82A114-9981-47D9-9F87-23C72CEA884A

P356

Q42504104-3B68C573-1103-4E9E-B330-8BB842C4CB2D

P407

Q42504104-2FAE27E2-9B67-4D9A-851D-B768F242A977

P433

Q42504104-254BFB42-F638-403C-B620-F2770417A1E2

P478

Q42504104-EA347A61-0426-48A2-A561-C4DC8F57DF11

P577

Q42504104-9E550C4D-7558-4D58-A427-3BACB124A9B2

P5875

Q42504104-B4B0C600-456F-4409-BA73-B70E356060A2

P698

Q42504104-D2325FE1-2994-41A2-A27A-DE7BED7A1A7E

P921

Q42504104-6D8C2506-46BF-4881-823C-FB07FC3A92FE

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Characterization of somatostat ...... lated human pancreatic islets.

@en

P2093

Bertram Wiedenmann

http://www.w3.org/2001/XMLSchema#string

Henning Jahr

http://www.w3.org/2001/XMLSchema#string

Mathias D Brendel

http://www.w3.org/2001/XMLSchema#string

Mathias Z Strowski

http://www.w3.org/2001/XMLSchema#string

Reinhard G Bretzel

http://www.w3.org/2001/XMLSchema#string

Stefan Mergler

http://www.w3.org/2001/XMLSchema#string

Sylvia Zacharias

http://www.w3.org/2001/XMLSchema#string

Ursula Plöckinger

http://www.w3.org/2001/XMLSchema#string

Vandana Singh

http://www.w3.org/2001/XMLSchema#string

P304

673-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2006-1578

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6691589

http://www.w3.org/2001/XMLSchema#string

P698

17105845

http://www.w3.org/2001/XMLSchema#string

P921